{"id":"https://openalex.org/W2004178182","doi":"https://doi.org/10.1002/hep.22570","title":"Atorvastatin prevents carbohydrate response element binding protein activation in the fructose\u2010fed rat by activating protein kinase A\u2020","display_name":"Atorvastatin prevents carbohydrate response element binding protein activation in the fructose\u2010fed rat by activating protein kinase A\u2020","alternate_titles":[],"publication_year":2008,"publication_date":"2008-08-05","ids":{"openalex":"https://openalex.org/W2004178182","doi":"https://doi.org/10.1002/hep.22570","mag":"2004178182","pmid":"https://pubmed.ncbi.nlm.nih.gov/19053045"},"language":"en","primary_location":{"id":"doi:10.1002/hep.22570","doi":"https://doi.org/10.1002/hep.22570","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hep.22570","pdf_url":null,"source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2004178182"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040190129","display_name":"Ricardo Rodr\u00edguez\u2010Calvo","orcid":"https://orcid.org/0000-0001-7513-0983","observed_orcids":["https://orcid.org/0000-0001-7513-0983"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210092133","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","ror":"https://ror.org/00dwgct76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4388891874","display_name":"Institut de Biomedicina de la Universitat de Barcelona","ror":"https://ror.org/01y43zx14","country_code":"ES","type":"education","lineage":["https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ricardo Rodr\u00edguez\u2010Calvo","raw_affiliation_strings":["Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III, University of Barcelona, Spain","Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III, University of Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I71999127"]},{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060552651","display_name":"Emma Barroso","orcid":"https://orcid.org/0000-0003-4551-4825","observed_orcids":["https://orcid.org/0000-0003-4551-4825"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210092133","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","ror":"https://ror.org/00dwgct76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4388891874","display_name":"Institut de Biomedicina de la Universitat de Barcelona","ror":"https://ror.org/01y43zx14","country_code":"ES","type":"education","lineage":["https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emma Barroso","raw_affiliation_strings":["Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053544166","display_name":"Luc\u00eda Serrano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210092133","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","ror":"https://ror.org/00dwgct76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4388891874","display_name":"Institut de Biomedicina de la Universitat de Barcelona","ror":"https://ror.org/01y43zx14","country_code":"ES","type":"education","lineage":["https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luc\u00eda Serrano","raw_affiliation_strings":["Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113710281","display_name":"Teresa Coll","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210092133","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","ror":"https://ror.org/00dwgct76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4388891874","display_name":"Institut de Biomedicina de la Universitat de Barcelona","ror":"https://ror.org/01y43zx14","country_code":"ES","type":"education","lineage":["https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Teresa Coll","raw_affiliation_strings":["Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rosa M. S\u00e1nchez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210092133","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","ror":"https://ror.org/00dwgct76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4388891874","display_name":"Institut de Biomedicina de la Universitat de Barcelona","ror":"https://ror.org/01y43zx14","country_code":"ES","type":"education","lineage":["https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rosa M. S\u00e1nchez","raw_affiliation_strings":["Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048779913","display_name":"Manuel Merlos","orcid":"https://orcid.org/0000-0002-8423-3033","observed_orcids":["https://orcid.org/0000-0002-8423-3033"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210092133","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","ror":"https://ror.org/00dwgct76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4388891874","display_name":"Institut de Biomedicina de la Universitat de Barcelona","ror":"https://ror.org/01y43zx14","country_code":"ES","type":"education","lineage":["https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Manuel Merlos","raw_affiliation_strings":["Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086489712","display_name":"Xavier Palomer","orcid":"https://orcid.org/0000-0001-7647-9984","observed_orcids":["https://orcid.org/0000-0001-7647-9984"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210092133","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","ror":"https://ror.org/00dwgct76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4388891874","display_name":"Institut de Biomedicina de la Universitat de Barcelona","ror":"https://ror.org/01y43zx14","country_code":"ES","type":"education","lineage":["https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xavier Palomer","raw_affiliation_strings":["Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043446902","display_name":"Juan Carlos Laguna","orcid":"https://orcid.org/0000-0002-7082-0704","observed_orcids":["https://orcid.org/0000-0002-7082-0704"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210092133","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","ror":"https://ror.org/00dwgct76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4388891874","display_name":"Institut de Biomedicina de la Universitat de Barcelona","ror":"https://ror.org/01y43zx14","country_code":"ES","type":"education","lineage":["https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Juan C. Laguna","raw_affiliation_strings":["Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031803983","display_name":"Manuel V\u00e1zquez\u2010Carrera","orcid":"https://orcid.org/0000-0001-7138-8207","observed_orcids":["https://orcid.org/0000-0001-7138-8207"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210092133","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","ror":"https://ror.org/00dwgct76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4388891874","display_name":"Institut de Biomedicina de la Universitat de Barcelona","ror":"https://ror.org/01y43zx14","country_code":"ES","type":"education","lineage":["https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Manuel V\u00e1zquez\u2010Carrera","raw_affiliation_strings":["Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","fax: (93)-4035982","Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigacio\u0301n Biome\u0301dica en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]},{"raw_affiliation_string":"fax: (93)-4035982","institution_ids":[]},{"raw_affiliation_string":"Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM)-Instituto de Salud Carlos III and Institut de Biomedicina de la Universidad de Barcelona (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5031803983"],"corresponding_institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4210115082","https://openalex.org/I4388891874","https://openalex.org/I71999127"],"apc_list":{"value":2900,"currency":"USD","value_usd":2900},"apc_paid":null,"fwci":1.5633,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.83404717,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"49","issue":"1","first_page":"106","last_page":"115"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12964","display_name":"Diet, Metabolism, and Disease","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12964","display_name":"Diet, Metabolism, and Disease","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.012799999676644802,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":1.0},{"id":"https://openalex.org/keywords/chrebp","display_name":"ChREBP","score":0.8799999952316284},{"id":"https://openalex.org/keywords/protein-kinase-a","display_name":"protein kinase A","score":0.8859999775886536},{"id":"https://openalex.org/keywords/fructose-feeding","display_name":"fructose feeding","score":0.9160000085830688},{"id":"https://openalex.org/keywords/hepatic-triglyceride-synthesis","display_name":"hepatic triglyceride synthesis","score":0.8130000233650208},{"id":"https://openalex.org/keywords/gpat1","display_name":"GPAT1","score":0.847000002861023},{"id":"https://openalex.org/keywords/carnitine-palmitoyltransferase-1","display_name":"carnitine palmitoyltransferase 1","score":0.9399999976158142},{"id":"https://openalex.org/keywords/srebp-1c","display_name":"SREBP-1c","score":0.9729999899864197},{"id":"https://openalex.org/keywords/fatty-acid-oxidation","display_name":"fatty acid oxidation","score":0.75},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.7900000214576721},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.5550000071525574},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.5730000138282776}],"concepts":[{"id":"https://openalex.org/C2853687","wikidata":"https://www.wikidata.org/wiki/Q18039976","display_name":"Carbohydrate-responsive element-binding protein","level":4,"score":0.9276581406593323},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.7894598245620728},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6531789302825928},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.6282735466957092},{"id":"https://openalex.org/C48289651","wikidata":"https://www.wikidata.org/wiki/Q106916817","display_name":"Fatty acid synthase","level":3,"score":0.6166806817054749},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6107557415962219},{"id":"https://openalex.org/C2776970464","wikidata":"https://www.wikidata.org/wiki/Q122043","display_name":"Fructose","level":2,"score":0.6047205924987793},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5147604942321777},{"id":"https://openalex.org/C2778977261","wikidata":"https://www.wikidata.org/wiki/Q11358","display_name":"Carbohydrate","level":2,"score":0.43928828835487366},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.373604416847229},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.33388277888298035},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.28327691555023193},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2733267545700073},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.12796670198440552},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.08043619990348816},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004040","descriptor_name":"Dietary Carbohydrates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005230","descriptor_name":"Fatty Acids, Nonesterified","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005992","descriptor_name":"Glycerol-3-Phosphate O-Acyltransferase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017868","descriptor_name":"Cyclic AMP-Dependent Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051778","descriptor_name":"Basic Helix-Loop-Helix Leucine Zipper Transcription Factors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051778","descriptor_name":"Basic Helix-Loop-Helix Leucine Zipper Transcription Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051780","descriptor_name":"Sterol Regulatory Element Binding Protein 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/hep.22570","doi":"https://doi.org/10.1002/hep.22570","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hep.22570","pdf_url":null,"source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},{"id":"pmid:19053045","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19053045","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology (Baltimore, Md.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1568303936","https://openalex.org/W1569955072","https://openalex.org/W1748636648","https://openalex.org/W1971679612","https://openalex.org/W2017895218","https://openalex.org/W2021657723","https://openalex.org/W2028886298","https://openalex.org/W2039543531","https://openalex.org/W2039928578","https://openalex.org/W2040119973","https://openalex.org/W2044842369","https://openalex.org/W2055837207","https://openalex.org/W2060503560","https://openalex.org/W2065735058","https://openalex.org/W2076713785","https://openalex.org/W2077256608","https://openalex.org/W2082058995","https://openalex.org/W2083819344","https://openalex.org/W2107825795","https://openalex.org/W2113961541","https://openalex.org/W2114656802","https://openalex.org/W2116023336","https://openalex.org/W2119296435","https://openalex.org/W2123420731","https://openalex.org/W2124753768","https://openalex.org/W2126582276","https://openalex.org/W2130813720","https://openalex.org/W2136472893","https://openalex.org/W2137988672","https://openalex.org/W2141501498","https://openalex.org/W2150138040","https://openalex.org/W2152557793","https://openalex.org/W2153673003","https://openalex.org/W2154411879","https://openalex.org/W2154447535","https://openalex.org/W2160870282","https://openalex.org/W2397977339"],"related_works":["https://openalex.org/W2126582276","https://openalex.org/W2007734334","https://openalex.org/W2128461670","https://openalex.org/W2328247544","https://openalex.org/W2040673772","https://openalex.org/W2151387277","https://openalex.org/W2106593184","https://openalex.org/W2040119973","https://openalex.org/W2156447884"],"abstract_inverted_index":{"UNLABELLED:":[0],"High":[1],"fructose":[2,223],"intake":[3],"contributes":[4],"to":[5,145,222],"the":[6,21,24,32,75,96,100,116,122,153,189,234,242,258,261],"overall":[7],"epidemic":[8],"of":[9,23,85,102,118,124,169,211,236,252,260],"obesity":[10],"and":[11,52,104,120,175,188,213,275],"metabolic":[12],"disease.":[13],"Here":[14],"we":[15],"examined":[16],"whether":[17],"atorvastatin":[18,138,165,239,270],"treatment":[19,114,183,201,240],"blocks":[20],"activation":[22],"carbohydrate":[25],"response":[26],"element":[27,178],"binding":[28,179],"protein":[29],"(ChREBP)":[30],"in":[31,155,191,233,246,257],"fructose-fed":[33],"rat.":[34],"Fructose":[35],"feeding":[36],"increased":[37,121,202,241],"blood":[38],"pressure":[39],"(21%,":[40],"P":[41,49,57,91,110,131,160],"<":[42,50,58,92,111,132,161],"0.05),":[43,93],"plasma":[44,53],"free":[45],"fatty":[46,140,146],"acids":[47,141],"(59%,":[48],"0.01),":[51],"triglyceride":[54,106,143,157],"levels":[55,84,158,245],"(129%,":[56],"0.001)":[59],"compared":[60],"with":[61,152],"control":[62],"rats":[63],"fed":[64,74],"standard":[65],"chow.":[66],"These":[67,134,266],"increases":[68,276],"were":[69,255],"prevented":[70,184],"by":[71,173,279],"atorvastatin.":[72,237],"Rats":[73],"fructose-rich":[76],"diet":[77],"showed":[78,224],"enhanced":[79,225],"hepatic":[80],"messenger":[81],"RNA":[82],"(mRNA)":[83],"glycerol-3-phosphate":[86],"acyltransferase":[87],"(Gpat1)":[88],"(1.45-fold":[89],"induction,":[90,109],"which":[94,149,207,229],"is":[95,150,171],"rate-limiting":[97],"enzyme":[98],"for":[99],"synthesis":[101,144],"triglycerides,":[103],"liver":[105,156],"content":[107],"(2.35-fold":[108],"0.001).":[112],"Drug":[113],"inhibited":[115],"induction":[117],"Gpat1":[119,170],"expression":[123,168,278],"liver-type":[125],"carnitine":[126],"palmitoyltransferase":[127],"1":[128],"(L-Cpt-1)":[129],"(128%,":[130],"0.01).":[133],"observations":[135],"indicate":[136,268],"that":[137,269],"diverts":[139],"from":[142],"acid":[147],"oxidation,":[148],"consistent":[151],"reduction":[154],"(28%,":[159],"0.01)":[162],"observed":[163,232],"after":[164],"treatment.":[166],"The":[167],"regulated":[172],"ChREBP":[174,186,192,212,226,273],"sterol":[176],"regulatory":[177],"protein-1c":[180],"(SREBP-1c).":[181],"Atorvastatin":[182],"fructose-induced":[185,272],"translocation":[187],"increase":[190],"DNA-binding":[193,198,216,227],"activity":[194,274],"while":[195],"reducing":[196],"SREBP-1c":[197],"activity.":[199,217],"Statin":[200],"phospho-protein":[203],"kinase":[204],"A":[205],"(PKA),":[206],"promotes":[208],"nuclear":[209],"exclusion":[210],"reduces":[214],"its":[215],"Human":[218],"HepG2":[219],"cells":[220],"exposed":[221],"activity,":[228],"was":[230],"not":[231],"presence":[235,259],"Furthermore,":[238],"CPT-I":[243,277],"mRNA":[244],"these":[247],"cells.":[248],"Interestingly,":[249],"both":[250],"effects":[251],"this":[253],"drug":[254],"abolished":[256],"PKA":[262],"inhibitor":[263],"H89.":[264],"CONCLUSION:":[265],"findings":[267],"inhibits":[271],"activating":[280],"PKA.":[281]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2004178182","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
